Isonics Corp. 

Ticker: ISON

Released After The Bell: Isonics Corporation Announces Strategic Initiatives for Fiscal Year 2005

Isonics Corporation, a leader in the development of isotopically engineered semiconductor materials, a supplier of silicon-on-insulator (SOI) wafers and isotopes for life sciences and health care applications, announced today its Strategic Initiatives for its 2005 fiscal year. The announcement was made by James E. Alexander, chairman, president and CEO of Isonics.

Mr. Alexander stated, "With our year-end coming to a close on April 30, and Isonics' strategic plan successfully being executed, we are enthusiastically announcing our strategic initiatives - which outline what we believe to be a compelling vision for the future of the company - for the upcoming 2005 fiscal year." 

During FY 2004 we successfully: 

• Solidified our life sciences segment by signing long-term supply agreements with existing and new customers for oxygen-18 and extending the joint production agreement with our Russian supplier, Global Scientific Technologies.
• Further developed our silicon-on-insulator (SOI) wafer manufacturing processes and signed a letter-of-intent to acquire the silicon wafer manufacturing business and related assets from EnCompass Materials Group Ltd. (EMG) of Vancouver, Washington, where (if we complete the acquisition) we plan to implement that SOI technology in high-volume manufacturing.
• Made significant advances with high thermal conductivity silicon-28 in customer evaluations, one of which may lead to our first commercial win
• Received a U.S. patent for isotopically engineered wafers, "Semiconductor Wafers with Integrated Heat Spreading Layer"
• Solidified our position in the homeland security market through the Company's subsidiary IUT Detection Technologies and its advanced neutron-based technology for detection of explosives and chemical/biological agents
• Raised over $5.5 million in equity financing which has positioned the Company for boldly executing our strategic initiatives 

To view the full news release please visit http://biz.yahoo.com/bw/040426/265995_1.html

Media Article: Nanotechnology, investing in tomorrow, today

A giant bet in nanotechnology may be the payoff of the century for investors who track this cutting edge technology.  Nano is big business and many companies are investing heavily. IBM's latest chip plant in East Fishkill NY cost $2.5 billion and lets the company make chips in the sub-micron range.

Although IBM  is not working in all areas of nanotech, the company is watching the entire industry carefully. It recently formed a group to see where IBM's nano initiatives can contribute to the life sciences field. The Armonk NY company today said it is collaborating with Stanford University on high-performance, low-power components to help build smaller and faster electronic devices. The partners said their latest research in the field of "spintronics" could lead to reconfigurable logic devices, room-temperature superconductors and quantum computers in the next five years.

Golden Colorado based Isonics has developed isotopically pure silicon-28 to replace natural silicon in the production of wafers for computer chips. Isotopically-pure silicon-28 has superior thermal properties compared to normal silicon. According to Isonics, customers are beginning to see meaningful temperature benefits in actual products made from Isonics' supplied silicon-28 epitaxial wafers. In March Isonics announced an agreement to acquire the silicon wafer manufacturing business and related assets from EnCompass Materials Group Ltd. (EMG) of Vancouver, Washington. . . 

To view the full media article please visit http://www.axcessnews.com/technology_042604.shtml

For a Complete Profile Please Visit http://www.smallcapreview.com/Ison.htm

Overview

Isonics Corporation is a diverse technology company, with burgeoning opportunities in semiconductors, pharmaceuticals, and homeland security. Much of its technology portfolio is based on nanotechnology processes and/or enablers for the manufacture of nanotechnology devices. The Company's motto - "Building businesses one atom at a time" -- is reflective of this. The Company is a recognized leader in the development of isotopically engineered semiconductor materials, and a supplier of silicon-on-insulator (SOI) wafers and isotopes for life sciences and healthcare applications.

ISON Investor Highlights

• Strong senior management team from GE
• Key patents and intellectual property
• Loyal customer base with secure long-term contracts in place
• $9.1M in sales in fiscal 2003 and growing
• Rapidly growing semiconductor segment
• Profitable and growing life sciences division

Profile

Semiconductor Division:

As an alternative to existing silicon wafer materials, Isonics has developed a semiconductor material (Silicon-28) with superior thermal conductivity properties. In March 2003, Isonics began shipping wafers and recording revenue.

The semiconductor industry trend toward increased power requirements and significantly higher operating temperatures has increased the need for materials that have superior thermal conductivity properties compared to natural, multi-isotopic materials. Early tests have shown that Isonics' Silicon-28 solution is compatible with virtually every other heat management solution currently implemented or envisioned to date. Importantly, it does not require changing a single device design or manufacturing process because isotopically-pure semiconductor materials are essentially chemically and physically identical to naturally-occurring semiconductor materials.

Life Sciences Division:

Isonics' Life Sciences division markets and sells stable isotopes for the health care industry such as carbon-13 for diagnostic breath tests and drug design, and radioisotopes and stable isotopes, such as oxygen-18, for positron emission tomography (PET) imaging. Through many long-term, exclusive supply relationships in place with producers, which have developed over 25 years, Isonics distributes products made by a variety of producers around the world. This profitable and growing division is vertically integrating manufacturing, distribution, and retail to capture higher revenue and improved margins.

Homeland Security Inititative:

In December 2002, Isonics acquired isotope-based trace detection technology that can be used to detect explosives and chemical and biological weapons. The Company acquired this technology from Institut of Umwelttechnologien GmbH (IUT), an entity in which it holds a 6% ownership interest.